Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases.

@article{Thakur1999AmphotericinBD,
  title={Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases.},
  author={C. P. Thakur and Ranjan Kumar Singh and Sahar Mahmoud Hassan and Raj Kumar and Shishir Narain and Ashwani Kumar},
  journal={Transactions of the Royal Society of Tropical Medicine and Hygiene},
  year={1999},
  volume={93 3},
  pages={319-23}
}
Out of 938 parasitologically confirmed patients with visceral leishmaniasis treated with amphotericin B (1 mg/kg bodyweight daily infused in 2 h for 20 days), 935 were cured clinically, 933 parasitologically and 931 ultimately (no relapse within 6 months). Two parasitologically 'not cured' and 4 relapsed patients were cured with 25 infusions, and 1 with double relapse with 30 infusions. The treatment was started only when serum haemoglobin reached 5 g/dL, serum electrolyte imbalance was… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 59 extracted citations

Novel selective inhibitor of Leishmania (Leishmania) amazonensis arginase.

Chemical biology & drug design • 2015
View 10 Excerpts
Highly Influenced

Drug policy for visceral leishmaniasis: a cost-effectiveness analysis.

Tropical medicine & international health : TM & IH • 2007
View 1 Excerpt
Highly Influenced

Is elimination of kala-azar feasible by 2017?

The Indian journal of medical research • 2016

Similar Papers

Loading similar papers…